Unlike increasing the antitumour immune response by controlling bile acid metabolism in liver cancer [28], our current study found that the microbiota significantly promoted the progression of Kras-driven lung cancer in mice, suggesting that changes in the gut microbiota can cause opposite effects in different organs (Figure 1). Here, KRAS is linked to lung carcinoma.